Servier appoints Yposkesi for lentiviral vector GMP-manufacturing in CAR-T cell development technology
Minoryx Therapeutics announces first patient dosed in the FRAMES phase 2 trial in Friedreich’s Ataxia
Biomunex Pharmaceuticals establishes US subsidiary
Seventure Partners renews support to Domain Therapeutics and invests €3.5M
GamaMabs Pharma to present updated results at 2019 ASCO Annual Meeting from the First-In-Human clinical study of murlentamab in advanced gynecological cancers
Bionure appoints Dr. Lucia Septien as chief medical offer
TreeFrog Therapeutics raises over €7M ($7.8M) in Series A financing round 6 months after incorporation
Neuroprotection Biotech Bionure Reports Successful Phase 1 Study for Lead Candidate BN201
